Colicraft 4.5 MIU

Colicraft Ingredients and Usage

The active ingredient is Colistimethate Sodium, a polymyxin E antibiotic. The 4.5 MIU powder requires reconstitution for intravenous infusion or nebulization.

Colicraft is clinically indicated for:

• Multidrug-resistant Pseudomonas aeruginosa infections
• Acinetobacter baumannii ventilator-associated pneumonia
• Carbapenem-resistant Enterobacteriaceae infections
• Cystic fibrosis pulmonary exacerbations

How Does Colicraft Work?

Colicraft provides bactericidal action through membrane disruption:

1. Cell Membrane Disruption: Binds to lipopolysaccharides in outer membrane
2. Increased Permeability: Causes leakage of intracellular contents
3. Bacterial Death: Leads to osmotic instability and cell lysis
4. Rapid Killing: Concentration-dependent bactericidal activity

Colicraft Side Effects and Warnings

Common side effects include nephrotoxicity, neurotoxicity, and respiratory muscle weakness. Most effects are dose-dependent and reversible.

Serious Considerations

1. Nephrotoxicity: Requires frequent renal function monitoring
2. Neurotoxicity: May cause dizziness, confusion, and neuromuscular blockade
3. Dosing Calculation: Use ideal body weight for dose calculation
4. Drug Interactions: Enhanced toxicity with other nephrotoxic drugs
5. Loading Dose: Recommended for serious infections in critically ill patients

Colicraft Storage Conditions

Colicraft Injection requires proper storage handling:

• Store below 25°C protected from light
• Use reconstituted solution within 24 hours if refrigerated
• Protect from moisture and freezing
• Discard if solution appears discolored or contains particles
• Follow aseptic preparation guidelines